Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 133, Issue 21
May 23 2019
Issue Cover

Table of Contents

BLOOD COMMENTARIES

GENE THERAPY
A novel therapeutic strategy for β-thalassemia
Tim M. Townes
View Articletitled, A novel therapeutic strategy for β-thalassemia
IMMUNOBIOLOGY AND IMMUNOTHERAPY
Anti-CD1a CAR T cells to selectively target T-ALL
Paul M. Maciocia,Martin A. Pule
View Articletitled, Anti-CD1a CAR T cells to selectively target T-ALL
MYELOID NEOPLASIA
NCAM1 supports therapy resistance and LSC function in AML
Stephen M. Sykes
View Articletitled, NCAM1 supports therapy resistance and LSC function in AML
PLATELETS AND THROMBOPOIESIS
Serotonin, key to thrombocytopenia in dengue?
Quirijn de Mast,Philip G. de Groot
View Articletitled, Serotonin, key to thrombocytopenia in dengue?
Red Cells, Iron, and Erythropoiesis
α-Globin pre-mRNA splicing, revisited
John G. Conboy
View Articletitled, <em>α-Globin</em> pre-mRNA splicing, revisited
MYELOID NEOPLASIA
JAK inhibitors and risk of B-cell lymphomas
Elisa Rumi,Silvia Zibellini
View Articletitled, JAK inhibitors and risk of B-cell lymphomas

PLENARY PAPER

GENE THERAPY
Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia
Brief Report
Shuqian Xu,Kevin Luk,Qiuming Yao,Anne H. Shen,Jing Zeng,Yuxuan Wu,Hong-Yuan Luo,Christian Brendel,Luca Pinello,David H. K. Chui,Scot A. Wolfe,Daniel E. Bauer

There is a Blood Commentary on this article in this issue.

View Articletitled, Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia
Supplemental data

BLOOD SPOTLIGHT

Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL
Chelsea L. Dieck,Adolfo Ferrando
View Articletitled, Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL

HOW I TREAT

How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism
Noel C. Chan,John W. Eikelboom
View Articletitled, How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism

IMMUNOBIOLOGY AND IMMUNOTHERAPY

PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell–inflamed phenotype
James Godfrey,Sravya Tumuluru,Riyue Bao,Michael Leukam,Girish Venkataraman,John Phillip,Carrie Fitzpatrick,James McElherne,Brendan W. MacNabb,Robert Orlowski,Sonali M. Smith,Justin Kline
View Articletitled, <em>PD-L1</em> gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell–inflamed phenotype
Supplemental data
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia
Clinical Trials & Observations
Diego Sánchez-Martínez,Matteo L. Baroni,Francisco Gutierrez-Agüera,Heleia Roca-Ho,Oscar Blanch-Lombarte,Sara González-García,Montserrat Torrebadell,Jordi Junca,Manuel Ramírez-Orellana,Talía Velasco-Hernández,Clara Bueno,José Luís Fuster,Julia G. Prado,Julien Calvo,Benjamin Uzan,Jan Cools,Mireia Camos,Françoise Pflumio,María Luisa Toribio,Pablo Menéndez

There is a Blood Commentary on this article in this issue.

View Articletitled, Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia
Supplemental data

MYELOID NEOPLASIA

NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML
Daniel Sasca,Jakub Szybinski,Andrea Schüler,Viral Shah,Jan Heidelberger,Patricia S. Haehnel,Anna Dolnik,Oliver Kriege,Eva-Marie Fehr,Wolf H. Gebhardt,George Reid,Claudia Scholl,Matthias Theobald,Lars Bullinger,Petra Beli,Thomas Kindler
View Articletitled, NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML
Supplemental data
Myelofibrosis osteoclasts are clonal and functionally impaired
Brief Report
Ivo Veletic,Taghi Manshouri,Asha S. Multani,C. Cameron Yin,Lei Chen,Srdan Verstovsek,Zeev Estrov
View Articletitled, Myelofibrosis osteoclasts are clonal and functionally impaired
Supplemental data

PLATELETS AND THROMBOPOIESIS

Peripheral serotonin causes dengue virus–induced thrombocytopenia through 5HT2 receptors
Mohamad Fadhli Bin Masri,Chinmay Kumar Mantri,Abhay P. S. Rathore,Ashley L. St. John
View Articletitled, Peripheral serotonin causes dengue virus–induced thrombocytopenia through 5HT<sub>2</sub> receptors
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

A cytosine-rich splice regulatory determinant enforces functional processing of the human α-globin gene transcript
Xinjun Ji,Jesse Humenik,Stephen A. Liebhaber
View Articletitled, A cytosine-rich splice regulatory determinant enforces functional processing of the human <em>α-globin</em> gene transcript
Supplemental data

LETTER TO BLOOD

Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy
Clinical Trials & Observations
Naveen Pemmaraju,Hagop Kantarjian,Loretta Nastoupil,Megan Dupuis,Lisa Zhou,Sherry Pierce,Keyur P. Patel,Lucia Masarova,Jorge Cortes,Srdan Verstovsek

There is a Blood Commentary on this article in this issue.

View Articletitled, Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy

BLOOD WORK

Reactive germinal centers in the bone marrow of an infant with autoimmune neutropenia
Weijie Li,Nazia Tabassum Iqbal
View Articletitled, Reactive germinal centers in the bone marrow of an infant with autoimmune neutropenia
Seronegative visceral leishmaniasis with bone marrow and hepatic involvement
Giovanni Martino,Stefano Ascani
View Articletitled, Seronegative visceral leishmaniasis with bone marrow and hepatic involvement
All Issues

Advertisement intended for health care professionals

Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia
Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads
Long-term Outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia
Leukemic myeloblasts with erythrophagocytosis

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals